Zacks Company Profile for Rennova Health, Inc. (RNVA : OTC) |
|
|
|
Company Description |
Rennova Health, Inc. provides diagnostics and supportive software solutions to healthcare providers. The Company's solutions include diagnostic solutions, revenue cycle management, healthcare software solutions, financial services, diagnostic laboratory testing and analytics for precision medicine, electronic health records and other software services. Rennova Health, Inc., formerly known as CollabRx, Inc., is headquartered in West Palm Beach, Florida.
Number of Employees: 149 |
|
|
|
Price / Volume Information |
Yesterday's Closing Price: $ |
Daily Weekly Monthly
 |
20 Day Moving Average: 867,104 shares |
Shares Outstanding: 43,051.32 (millions) |
Market Capitalization: $ (millions) |
Beta: 17.59 |
52 Week High: $0.00 |
52 Week Low: $0.00 |
Short Interest Ratio: |
|
% Price Change |
% Price Change Relative to S&P 500 |
4 Week |
% |
% |
12 Week |
% |
% |
Year To Date |
% |
% |
|
|
|
|
|
|
|
General Corporate Information |
Officers
Seamus Lagan - Chief Executive Officer; President; Director; and
Trevor Langley - Director
Gary L. Blum - Director
Christopher E. Diamantis - Director
Trevor Langley - Director
|
|
Peer Information
Rennova Health, Inc. (HLIS)
Rennova Health, Inc. (AZTA)
Rennova Health, Inc. (APYI)
Rennova Health, Inc. (RNVA)
Rennova Health, Inc. (HMSY)
Rennova Health, Inc. (LRSI)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MEDICAL INFO SYS
Sector: Medical
CUSIP: 759757867
SIC: 8062
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: -
Next Expected EPS Date: -
|
|
Share - Related Items
Shares Outstanding: 43,051.32
Most Recent Split Date: 7.00 (0.00:1)
Beta: 17.59
Market Capitalization: $ (millions)
|
|
|
|
|
|
EPS Information |
Dividend Information |
Analyst Coverage: No |
Dividend Yield: % |
Current Fiscal Quarter EPS Consensus Estimate: $ |
Indicated Annual Dividend: $0.00 |
Current Fiscal Year EPS Consensus Estimate: $ |
Payout Ratio: |
Number of Estimates in the Fiscal Year Consensus: |
Change In Payout Ratio: |
Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
Next EPS Report Date: - |
|
|
|
|